JP2017025071A5 - - Google Patents

Download PDF

Info

Publication number
JP2017025071A5
JP2017025071A5 JP2016159713A JP2016159713A JP2017025071A5 JP 2017025071 A5 JP2017025071 A5 JP 2017025071A5 JP 2016159713 A JP2016159713 A JP 2016159713A JP 2016159713 A JP2016159713 A JP 2016159713A JP 2017025071 A5 JP2017025071 A5 JP 2017025071A5
Authority
JP
Japan
Prior art keywords
anticancer agent
agent according
group
hydrogen
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016159713A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017025071A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017025071A publication Critical patent/JP2017025071A/ja
Publication of JP2017025071A5 publication Critical patent/JP2017025071A5/ja
Pending legal-status Critical Current

Links

JP2016159713A 2004-09-07 2016-08-16 塞栓剤からの薬物送達 Pending JP2017025071A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04255411 2004-09-07
EP04255411.3 2004-09-07

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015080262A Division JP2015180625A (ja) 2004-09-07 2015-04-09 塞栓剤からの薬物送達

Publications (2)

Publication Number Publication Date
JP2017025071A JP2017025071A (ja) 2017-02-02
JP2017025071A5 true JP2017025071A5 (enExample) 2017-03-09

Family

ID=34930630

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2007529390A Expired - Lifetime JP5221134B2 (ja) 2004-09-07 2005-09-06 塞栓剤からの薬物送達
JP2012167295A Expired - Lifetime JP5792691B2 (ja) 2004-09-07 2012-07-27 塞栓剤からの薬物送達
JP2015080262A Pending JP2015180625A (ja) 2004-09-07 2015-04-09 塞栓剤からの薬物送達
JP2016159713A Pending JP2017025071A (ja) 2004-09-07 2016-08-16 塞栓剤からの薬物送達

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2007529390A Expired - Lifetime JP5221134B2 (ja) 2004-09-07 2005-09-06 塞栓剤からの薬物送達
JP2012167295A Expired - Lifetime JP5792691B2 (ja) 2004-09-07 2012-07-27 塞栓剤からの薬物送達
JP2015080262A Pending JP2015180625A (ja) 2004-09-07 2015-04-09 塞栓剤からの薬物送達

Country Status (11)

Country Link
US (3) US20070275991A1 (enExample)
EP (3) EP2269580A3 (enExample)
JP (4) JP5221134B2 (enExample)
CN (2) CN103860479A (enExample)
AT (1) ATE505185T1 (enExample)
AU (1) AU2005281483B2 (enExample)
CA (1) CA2579533C (enExample)
DE (1) DE602005027477D1 (enExample)
ES (1) ES2361919T3 (enExample)
HK (1) HK1198691A1 (enExample)
WO (1) WO2006027567A2 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080046750A (ko) 2000-03-24 2008-05-27 바이오스피어 메디칼 인코포레이티드 능동 색전화용 미소구
WO2006013376A2 (en) * 2004-08-04 2006-02-09 Biocompatibles Uk Limited Drug delivery of a cox inhibitor from embolic agents
MX2007013914A (es) 2005-05-09 2008-02-22 Biosphere Medical S A Composiciones y metodos que usan microesferas y agentes de contraste no ionicos.
JP5189089B2 (ja) 2006-06-22 2013-04-24 バイオコンパティブルズ ユーケー リミテッド 再水和可能な製薬製品
EP1985286A1 (en) * 2007-04-24 2008-10-29 Biocompatibles UK Limited Microspheres for treatment of brain tumours
EP2190409B9 (en) * 2007-08-16 2019-03-06 Biocompatibles UK Limited Delivery of drug combinations
AU2009321621B2 (en) * 2008-12-02 2013-06-13 Biocompatibles Uk Limited Pancreatic tumour treatment
EP2646000B1 (en) 2010-11-29 2015-04-29 Centre Hospitalier Universitaire Vaudois Chemoembolization composition comprising anti-angiogenic agents
US10307167B2 (en) 2012-12-14 2019-06-04 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
US10813630B2 (en) 2011-08-09 2020-10-27 Corquest Medical, Inc. Closure system for atrial wall
US10314594B2 (en) 2012-12-14 2019-06-11 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
CN102336904B (zh) * 2011-09-29 2013-03-27 成都一平医药科技发展有限公司 一种喜树碱及其衍生物的多价peg修饰物及其用途
CN102397593B (zh) * 2011-11-11 2013-12-18 北京大学 X线下可显影的栓塞微粒及其制备方法和应用
KR101563968B1 (ko) * 2012-11-15 2015-10-29 재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 알부민 및 덱스트란 설페이트를 포함하는 항암제 흡착능력이 향상된 생분해성 마이크로 비드 및 이의 제조방법
US20140142689A1 (en) 2012-11-21 2014-05-22 Didier De Canniere Device and method of treating heart valve malfunction
JP6049901B2 (ja) 2012-11-27 2016-12-21 ユタ−イナ ディーディーエス アンド アドバンスト セラピューティクス リサーチ センター 陰イオン性高分子を含む抗癌剤吸着能力の向上された生分解性マイクロビーズ及びその製造方法
CA2923753C (en) 2013-09-19 2021-10-12 Terumo Corporation Polymer particles
BR112016005768B1 (pt) 2013-09-19 2021-09-21 Microvention, Inc Películas de polímero
EP3065719A4 (en) 2013-11-08 2017-08-09 Terumo Corporation Polymer particles
US9566443B2 (en) 2013-11-26 2017-02-14 Corquest Medical, Inc. System for treating heart valve malfunction including mitral regurgitation
US10842626B2 (en) 2014-12-09 2020-11-24 Didier De Canniere Intracardiac device to correct mitral regurgitation
JP2016124818A (ja) * 2014-12-26 2016-07-11 日本化薬株式会社 転移性肝癌治療薬及び転移性肝癌の治療方法
US9907880B2 (en) 2015-03-26 2018-03-06 Microvention, Inc. Particles
WO2016203337A2 (en) * 2015-06-14 2016-12-22 Mohan M Alapati Compositions and methods for the treatment of cancer
WO2016203352A2 (en) * 2015-06-14 2016-12-22 Mohan M Alapati Compositions and methods for the treatment of cancer
GB201515602D0 (en) * 2015-09-03 2015-10-21 Biocompatibles Uk Ltd Polymers and microspheres
CA3038642C (en) 2016-09-28 2021-11-02 Terumo Corporation Polymer particles comprising polymerizable pharmaceutical agents
KR102693361B1 (ko) 2017-05-26 2024-08-09 브루인 바이오사이언시스, 인크. 화학색전제
CN107812232A (zh) * 2017-11-08 2018-03-20 华威(深圳)医疗器械有限责任公司 可显影羧基改性聚乙烯醇微球栓塞剂及其制备工艺
JP7198529B2 (ja) * 2018-11-30 2023-01-04 ネクストバイオメディカル カンパニー リミテッド 生分解性高分子を含む化学塞栓用水和ゲル粒子
GB201918300D0 (en) * 2019-12-12 2020-01-29 Extruded Pharmaceuticals Ltd Chemotherapeutic drug implant

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4032561A (en) * 1975-05-27 1977-06-28 The Upjohn Company 17-Phenyl-18,19,20-trinor-cis-4,5-didehydro-PGF1.sub.α compounds
US4224427A (en) 1978-06-01 1980-09-23 Ciba-Geigy Corporation Process for preparing hydrogels as spherical beads of large size
JPS6019790A (ja) * 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US4978713A (en) 1987-12-16 1990-12-18 Ciba-Geigy Corporation Polyvinyl alcohol derivatives containing pendant vinylic monomer reaction product units bound through ether groups and hydrogel contact lenses made therefrom
GB9023498D0 (en) 1990-10-29 1990-12-12 Biocompatibles Ltd Soft contact lens material
US5559235A (en) * 1991-10-29 1996-09-24 Glaxo Wellcome Inc. Water soluble camptothecin derivatives
GB9301702D0 (en) 1993-01-28 1993-03-17 Biocompatibles Ltd New materials
GB9301701D0 (en) 1993-01-28 1993-03-17 Biocompatibles Ltd New zwitterionic materials
TW272976B (enExample) 1993-08-06 1996-03-21 Ciba Geigy Ag
GB9415926D0 (en) 1994-08-04 1994-09-28 Biocompatibles Ltd New materials
CA2192725C (en) * 1995-12-28 2004-04-20 Kenji Tsujihara Camptothecin derivatives
WO2000029481A1 (en) 1998-11-13 2000-05-25 Biocompatibles Limited Anionic-cationic polyion complexes comprising zwitterionic monomer component
US6958212B1 (en) * 1999-02-01 2005-10-25 Eidgenossische Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
DE19905639A1 (de) * 1999-02-11 2000-08-17 Clariant Gmbh Wasserlösliche oder wasserquellbare Polymerisate
FR2793684B1 (fr) 1999-05-17 2001-08-10 Ethypharm Lab Prod Ethiques Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant
US6191119B1 (en) * 1999-10-15 2001-02-20 Supergen, Inc. Combination therapy including 9-nitro-20(S)-camptothecin
JP2002154963A (ja) * 2000-11-14 2002-05-28 Yakult Honsha Co Ltd 徐放性抗腫瘍剤
US7838699B2 (en) * 2002-05-08 2010-11-23 Biosphere Medical Embolization using degradable crosslinked hydrogels
DE10230991A1 (de) 2002-07-10 2004-02-12 Robert Bosch Gmbh Werkzeugaufnahme für eine Werkzeugmaschine
US20040076582A1 (en) * 2002-08-30 2004-04-22 Dimatteo Kristian Agent delivery particle
ES2308149T3 (es) * 2003-02-12 2008-12-01 Biocompatibles Uk Limited Composicion para la quimioemboloterapia de tumores solidos.
US20040161466A1 (en) * 2003-02-14 2004-08-19 Biocompatibles Uk Limited Chemoembolisation

Similar Documents

Publication Publication Date Title
JP2017025071A5 (enExample)
CN102985452B (zh) 包含丙烯酸的碱溶胀性丙烯酸乳液、其在水性制剂中的用途以及含有所述乳液的制剂
CA2543553A1 (en) Nanoparticulate active substance formulations
JP2005515278A5 (enExample)
JP2016216465A5 (enExample)
JP2014087796A5 (enExample)
JP2007523235A5 (enExample)
JP2016523833A5 (enExample)
JP6262873B2 (ja) 歯科用グラスアイオノマーセメント組成物及びその製造方法
CN105051605A (zh) 平版印刷产生的特征
JP2016104119A5 (enExample)
JP2014533319A5 (enExample)
BR112017022642B1 (pt) Composição, e, método
WO2012142126A3 (en) Method of making radiation-sensitive sol-gel materials
CN104387519A (zh) 一种纳米阳离子氟碳聚合物乳液及其制备方法
JPWO2016104261A1 (ja) 結合剤および水溶液
JP2011136977A5 (enExample)
JP2016020461A5 (enExample)
RU2017125436A (ru) Покровная композиция на водной основе, применение такой композиции, способ покрытия подложки с применением такой композиции и покрытые подложки
CN105153357B (zh) 一种氟封端的环氧聚合物和制备方法及其在制备疏水表面的应用
JP2019510830A5 (enExample)
CN107075279A (zh) 包含含有甲硅烷酯基团的聚合物和含有季铵/鏻磺酸盐基团的聚合物的污染控制涂料组合物
ES2592913T3 (es) Partículas nanocompuestas eléctricamente conductoras que poseen un núcleo de poliacrilato de alquilo y un recubrimiento de polianilina
JP2013540204A5 (enExample)
ES2833953T3 (es) Látex de polímero híbrido orgánico-inorgánico para pintura para señalización de tráfico de alta duración